112 related articles for article (PubMed ID: 29849774)
1. The recombinant BMP-2 loaded silk fibroin microspheres improved the bone phenotype of mild osteogenesis imperfecta mice.
Fu T; Liu Y; Wang Z; Jing Y; Zhao Y; Shao C; Lv Z; Li G
PeerJ; 2023; 11():e16191. PubMed ID: 37927786
[TBL] [Abstract][Full Text] [Related]
2. Unraveling the Role of Endothelial Dysfunction in Osteonecrosis of the Femoral Head: A Pathway to New Therapies.
Shao W; Wang P; Lv X; Wang B; Gong S; Feng Y
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540277
[TBL] [Abstract][Full Text] [Related]
3. Osteonecrosis of the femoral head: treatment with ancillary growth factors.
Houdek MT; Wyles CC; Sierra RJ
Curr Rev Musculoskelet Med; 2015 Sep; 8(3):233-9. PubMed ID: 25985987
[TBL] [Abstract][Full Text] [Related]
4. Editorial: New insight into immune cells in the development of non-traumatic osteonecrosis of the femoral head.
Zhou Y; Ma J; Zhang Q; Wang B
Front Cell Dev Biol; 2024; 12():1388531. PubMed ID: 38774647
[No Abstract] [Full Text] [Related]
5. Editorial for Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version).
Hopkins C; Genant HK
J Orthop Translat; 2020 Mar; 21():A1. PubMed ID: 32309141
[No Abstract] [Full Text] [Related]
6. Commentary: "Evolutionary course of the femoral head osteonecrosis: Histopathological - radiologic characteristics and clinical staging systems".
Qin L
J Orthop Translat; 2021 Nov; 31():139. PubMed ID: 35024337
[No Abstract] [Full Text] [Related]
7. Retracted: Integrated Analysis of miRNA-mRNA Regulatory Networks Associated with Osteonecrosis of the Femoral Head.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9848930. PubMed ID: 37388030
[TBL] [Abstract][Full Text] [Related]
8. Abnormal Variations of the Key Genes in Osteoporotic Fractures.
Wang B; Mai C; Pan L
Emerg Med Int; 2022; 2022():1022078. PubMed ID: 37008288
[TBL] [Abstract][Full Text] [Related]
9. Recent development in multizonal scaffolds for osteochondral regeneration.
Yu L; Cavelier S; Hannon B; Wei M
Bioact Mater; 2023 Jul; 25():122-159. PubMed ID: 36817819
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of urinary exosomal hsa-microRNA-200b-3p and hsa-microRNA-206 in patients of steroid-induced osteonecrosis of femoral head.
Chen D; Zhang G; Li Y; Zhang M; He Q; Yang J; Wen L; Zou X; Li Z; Wang H; Chen P
Am J Transl Res; 2021; 13(7):7574-7590. PubMed ID: 34377236
[TBL] [Abstract][Full Text] [Related]
11. Co-transfection with
Hu Y; Zhao QW; Wang ZC; Fang QQ; Zhu H; Hong DS; Liang XG; Lou D; Tan WQ
J Int Med Res; 2021 Mar; 49(3):300060521997679. PubMed ID: 33769121
[TBL] [Abstract][Full Text] [Related]
12. The combination of PLLA/PLGA/PCL composite scaffolds integrated with BMP-2-loaded microspheres and low-intensity pulsed ultrasound alleviates steroid-induced osteonecrosis of the femoral head.
Zhu H; Shi Z; Cai X; Yang X; Zhou C
Exp Ther Med; 2020 Dec; 20(6):126. PubMed ID: 33005252
[TBL] [Abstract][Full Text] [Related]
13. Grafting, Stripping and Stapling of Helical Peptides from the Dimerization Interface of ONFH-Related Bone Morphogenetic Protein-2.
Song W; Wang K; Wang W; Yang P; Dang X
Protein J; 2019 Feb; 38(1):12-22. PubMed ID: 30604108
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-2 exhibits therapeutic benefits for osteonecrosis of the femoral head through induction of cartilage and bone cells.
Wang C; Zang H; Zhou D
Exp Ther Med; 2018 May; 15(5):4298-4308. PubMed ID: 29849774
[TBL] [Abstract][Full Text] [Related]
15. Platelet-rich plasma has beneficial effects in mice with osteonecrosis of the femoral head by promoting angiogenesis.
Tong S; Yin J; Liu J
Exp Ther Med; 2018 Feb; 15(2):1781-1788. PubMed ID: 29434765
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor improves bone regeneration via the bone morphogenetic protein‑2‑mediated NF‑κB signaling pathway.
Zhen R; Yang J; Wang Y; Li Y; Chen B; Song Y; Ma G; Yang B
Mol Med Rep; 2018 Apr; 17(4):6045-6053. PubMed ID: 29436622
[TBL] [Abstract][Full Text] [Related]
17. RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis.
Kim HK; Morgan-Bagley S; Kostenuik P
J Bone Miner Res; 2006 Dec; 21(12):1946-54. PubMed ID: 17002576
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors.
Mont MA; Jones LC; Einhorn TA; Hungerford DS; Reddi AH
Clin Orthop Relat Res; 1998 Oct; (355 Suppl):S314-35. PubMed ID: 9917651
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
